Skip to main content

Ewing’s Sarcoma: Current Concepts in Chemotherapy and Surgical Control

  • Chapter
  • First Online:
Pediatric Cancer, Volume 4

Part of the book series: Pediatric Cancer ((PECA,volume 4))

Abstract

Ewing sarcoma is a relatively rare tumor of childhood and constitutes 3% of all pediatric malignancies. It is pathologically a malignant round cell tumor, CD99 positive on immunohistochemical staining and characterized by a unique translocation, t(11;22). The most common presenting symptoms are persistent pain and swelling. Imaging of primary site and biopsy are essential for confirmation of diagnosis and staging work-up includes bone marrow biopsy, bone scan and CT scan of chest. A comprehensive multidisciplinary approach incorporating multiagent chemotherapy along with surgery and or radiation therapy is the standard of care. Outcome of patients with localized disease has improved considerably but remains dismal for those with metastatic and recurrent disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Arai Y, Kun LE, Brooks MT, Fairclough DL, Fontanesi J, Meyer WH, Hayes FA, Thompson E, Rao BN (1991) Ewing’s sarcoma: local tumor control and patterns of failure following limited-volume radiation therapy. Int J Radiat Oncol Biol Phys 21:1501–1508

    Article  PubMed  CAS  Google Scholar 

  • Benini S, Manara MC, Baldini N, Cerisano V, Serra M, Mercuri M, Lollini PL, Nanni P, Picci P, Scotlandi K (2001) Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing’s sarcoma cells. Clin Cancer Res 7:1790–1797

    PubMed  CAS  Google Scholar 

  • Burgert EO Jr, Nesbit ME, Garnsey LA, Gehan EA, Herrmann J, Vietti TJ, Cangir A, Tefft M, Evans R, Thomas P (1990) Multimodal therapy for the management of nonpelvic, localized Ewing’s sarcoma of bone: intergroup study IESS-II. J Clin Oncol 8:1514–1524

    PubMed  Google Scholar 

  • Craft AW, Cotterill SJ, Bullimore JA, Pearson D (1997) Long-term results from the first UKCCSG Ewing’s Tumour Study (ET-1). United Kingdom Children’s Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party. Eur J Cancer 33:1061–1069

    Article  PubMed  CAS  Google Scholar 

  • Craft A, Cotterill S, Malcolm A, Spooner D, Grimer R, Souhami R, Imeson J, Lewis I (1998) Ifosfamide-containing chemotherapy in Ewing’s sarcoma: The second United Kingdom Children’s Cancer Study Group and the Medical Research Council Ewing’s Tumor Study. J Clin Oncol 16:3628–3633

    PubMed  CAS  Google Scholar 

  • Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, Ambros PF, Sheer D, Turc-Carel C, Triche TJ, Alain A, Gilles T (1994) The Ewing family of tumors: a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 331:294–299

    Article  PubMed  CAS  Google Scholar 

  • Ewing J (1921) Diffuse endothelioma of bone. Proc NY Pathol Soc 21:17–24

    Google Scholar 

  • Frouge C, Vanel D, Coffre C, Couanet D, Contesso G, Sarrazin D (1988) The role of magnetic resonance imaging in the evaluation of Ewing sarcoma. A report of 27 cases. Skeletal Radiol 17:387–392

    Article  PubMed  CAS  Google Scholar 

  • Granowetter L, Womer R, Devidas M, Krailo M, Wang C, Bernstein M, Marina N, Leavey P, Gebhardt M, Healey J, Shamberger RC, Goorin A, Miser J, Meyer J, Arndt CA, Sailer S, Marcus K, Perlman E, Dickman P, Grier HE (2009) Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children’s Oncology Group Study. J Clin Oncol 27(15):2536–2541

    Article  PubMed  CAS  Google Scholar 

  • Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt M, Dickman P, Perlman EJ, Meyers P, Donaldson S, Moore S, Rausen AR, Vietti TJ, Miser JS (2003) Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 348:694–701

    Article  PubMed  CAS  Google Scholar 

  • Gurney JG, Severson RK, Davis S, Robison LL (1975) Incidence of cancer in children in the United States. Cancer 75:2186–2195

    Article  Google Scholar 

  • Hustu HO, Holton C, James D Jr, Pinkel D (1968) Treatment of Ewing’s sarcoma with concurrent radiotherapy and chemotherapy. J Pediatr 73:249–251

    Article  PubMed  CAS  Google Scholar 

  • Juergens C, Weston C, Lewis I, Whelan J, Paulussen M, Oberlin O, Michon J, Zoubek A, Juergens H, Craft A (2006) Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial. Pediatr Blood Cancer 47:22–29

    Article  PubMed  Google Scholar 

  • Juergens H, Manner D, Gerss J, Ranfit A, Paulussen M, Dirksen U (2009) TNM staging in Ewing sarcomas. Pediatr Blood Cancer 53(5):759

    Google Scholar 

  • Kawaguchi N, Ahmed AR, Matsumoto S, Manabe J, Matsushita Y (2004) The concept of curative margin in surgery for bone and soft tissue sarcoma. Clin Orthop Relat Res 419:165–172

    Article  PubMed  Google Scholar 

  • Kim JH, Kang HG, Kim HS (2010) MRI-guided navigation surgery with temporary implantable bone markers in limb salvage for sarcoma. Clin Orthop Relat Res 468(8):2211–2217

    Article  PubMed  Google Scholar 

  • Kovar H, Aryee DN, Jug G, Henockl C, Schemper M, Delattre O, Thomas G, Gadner H (1996) EWS/FLI-1 antagonists induce growth inhibition of Ewing’s tumor cells in vitro. Cell Growth Differ 7:429–437

    PubMed  CAS  Google Scholar 

  • Maki RG, Wathen JK, Patel SR, Priebat DA, Okuno SH, Samuels B, Fanucchi M, Harmon DC, Schuetze SM, Reinke D, Thall PF, Benjamin RS, Baker LH, Hensley ML (2007) Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002. J Clin Oncol 25:2755–2763

    Article  PubMed  CAS  Google Scholar 

  • Mankin HJ, Mankin CJ, Simon MA (1996) The hazards of the biopsy, revisited. Members of the musculoskeletal tumor society. J Bone Joint Surg Am 78:656–663

    PubMed  CAS  Google Scholar 

  • May WA, Gishizky ML, Lessnick SL, Lunsford LB, Lewis BC, Delattre O, Zucman J, Thomas G, Denny CT (1993) Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc Natl Acad Sci U S A 90:5752–5756

    Article  PubMed  CAS  Google Scholar 

  • Meyers PA, Krailo MD, Ladanyi M, Chan KW, Sailer SL, Dickman PS, Baker DL, Davis JH, Gerbing RB, Grovas A, Herzog CE, Lindsley KL, Liu-Mares W, Nachman JB, Sieger L, Wadman J, Gorlick RG (2001) High-dose melphalan, etoposide, total body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing’s sarcoma does not improve prognosis. J Clin Oncol 19:2812–2820

    PubMed  CAS  Google Scholar 

  • Nesbit ME Jr, Gehan EA, Burgert EO Jr, Vietti TJ, Cangir A, Tefft M, Evans R, Thomas P, Askin FB, Kissane JM (1990) Multimodal therapy for the management of primary, nonmetastatic Ewing’s sarcoma of bone: a long-term follow-up of the First Intergroup study. J Clin Oncol 8:1664–1674

    PubMed  Google Scholar 

  • Palumbo BT, Henderson ER, Groundland JS, Cheong D, Pala E, Letson GD, Ruggier P (2011) Advances in segmental endoprosthetic reconstruction for extremity tumors: a review of contemporary designs and techniques. Cancer Control 18(3):160–170

    PubMed  Google Scholar 

  • Paulussen M, Ahrens S, Dunst J, Winkelmann W, Exner GU, Kotz R, Amann G, Dockhorn-Dworniczak B, Harms D, Müller-Weihrich S, Welte K, Kornhuber B, Janka-Schaub G, Göbel U, Treuner J, Voûte PA, Zoubek A, Gadner H, Jürgens H (2001a) Localized Ewing tumor of bone: final results of the coopertive Ewing’s Sarcoma Study CESS 86. J Clin Oncol 19:1818–1829

    PubMed  CAS  Google Scholar 

  • Paulussen M, Ahrens S, Lehnert M, Taeger D, Hense HW, Wagner A, Dunst J, Harms D, Reiter A, Henze G, Niemeyer C, Göbel U, Kremens B, Fölsch UR, Aulitzky WE, Voûte PA, Zoubek A, Jürgens H (2001b) Second malignancies after Ewing’s tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study. Ann Oncol 12:1619–1630

    Article  PubMed  CAS  Google Scholar 

  • Paulussen M, Craft AW, Lewis I, Hackshaw A, Douglas C, Dunst J, Schuck A, Winkelmann W, Köhler G, Poremba C, Zoubek A, Ladenstein R, van den Berg H, Hunold A, Cassoni A, Spooner D, Grimer R, Whelan J, McTiernan A, Jürgens H (2008) Results of the EICESS-92 Study: two randomized trials of Ewing’s sarcoma treatment—cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. J Clin Oncol 26:4385–4393

    Article  PubMed  CAS  Google Scholar 

  • Pinkel D (1962) Cyclophosphamide in children with cancer. Cancer 15:42–49

    Article  PubMed  CAS  Google Scholar 

  • Puri A, Gulia A, Agarwal M, Jambhekar N, Laskar S (2010) Extracorporeal irradiated tumor bone: a reconstruction option in diaphyseal Ewing’s sarcomas. Indian J Orthop 44(4):390–396

    Article  PubMed  Google Scholar 

  • Rodríguez-Galindo C, Navid F, Liu T, Billups CA, Rao BN, Krasin MJ (2008) Prognostic factors for local and distant control in Ewing sarcoma family of tumors. Ann Oncol 19:814–820

    Article  PubMed  Google Scholar 

  • Rosen G, Wollner N, Tan C, Wu SJ, Hajdu SI, Cham W, D’Angio GJ, Murphy ML (1974) Proceedings: disease-free survival in children with Ewing’s sarcoma treated with radiation therapy and adjuvant four-drug sequential chemotherapy. Cancer 33:384–393

    Article  PubMed  CAS  Google Scholar 

  • Saylors RL III, Stine KC, Sullivan J, Kepner JL, Wall DA, Bernstein ML, Harris MB, Hayashi R, Vietti TJ (2001) Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study. J Clin Oncol 19:3463–3469

    PubMed  CAS  Google Scholar 

  • Steinherz LJ, Steinherz PG, Tan CTC, Heller G, Murphy ML (1991) Cardiac toxicity 4–20 years after completing anthracycline therapy. JAMA 266:1672–1677

    Article  PubMed  CAS  Google Scholar 

  • Sutow WW, Sullivan MP (1962) Cyclophosphamide therapy in children with Ewing’s sarcoma. Cancer Chemother Rep 23:55–60

    PubMed  CAS  Google Scholar 

  • Wagner LM, Crews KR, Iacono LC, Houghton PJ, Fuller CE, McCarville MB, Goldsby RE, Albritton K, Stewart CF, Santana VM (2004) Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors. Clin Cancer Res 10:840–848

    Article  PubMed  CAS  Google Scholar 

  • Womer R, West D, Krailo M, Dickman P, Pawel B (2008) Chemotherapy intensification by interval compression in localized Ewing sarcoma family tumors (ESFT). Proc Am Soc Clin Oncol 26:abstr 10504

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gauri Kapoor .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Kapoor, G., Jain, S., Tiwari, A. (2013). Ewing’s Sarcoma: Current Concepts in Chemotherapy and Surgical Control. In: Hayat, M. (eds) Pediatric Cancer, Volume 4. Pediatric Cancer, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6591-7_22

Download citation

Publish with us

Policies and ethics